Harnessing the Clinical Efficacy of Phosphodiesterase 4 Inhibitors in Inflammatory Lung Diseases: Dual-Selective Phosphodiesterase Inhibitors and Novel Combination Therapies-Reference-Cited by-同舟云学术

Harnessing the Clinical Efficacy of Phosphodiesterase 4 Inhibitors in Inflammatory Lung Diseases: Dual-Selective Phosphodiesterase Inhibitors and Novel Combination Therapies

Published:2011 Issue: Volume: Page:415-446
ISSN:0171-2004
Container-title:Phosphodiesterases as Drug Targets
language:
Short-container-title:

Author:

Giembycz Mark A.,Newton Robert

Publisher

Springer Berlin Heidelberg

Link

http://link.springer.com/content/pdf/10.1007/978-3-642-17969-3_18.pdf

Reference212 articles.

1. Alp S, Skrygan M, Schmidt WE, Bastian A (2006) Sildenafil improves hemodynamic parameters in COPD – an investigation of six patients. Pulm Pharmacol Ther 19:386–390

2. Ammit AJ, Hoffman RK, Amrani Y, Lazaar AL, Hay DW, Torphy TJ, Penn RB, Panettieri RA (2000) Tumor necrosis factor-α-induced secretion of RANTES and interleukin-6 from human airway smooth-muscle cells. Modulation by cyclic adenosine monophosphate. Am J Respir Cell Mol Biol 23:794–802

3. Ammit AJ, Lazaar AL, Irani C, O'Neill GM, Gordon ND, Amrani Y, Penn RB, Panettieri RA (2002) Tumor necrosis factor-α-induced secretion of RANTES and interleukin-6 from human airway smooth muscle cells: modulation by glucocorticoids and β-agonists. Am J Respir Cell Mol Biol 26:465–474

4. Amsallem E, Kasparian C, Haddour G, Boissel JP, Nony P (2005) Phosphodiesterase III inhibitors for heart failure. Cochrane Database Syst Rev CD002230

5. Amsterdam A, Sasson R (2002) The anti-inflammatory action of glucocorticoids is mediated by cell type specific regulation of apoptosis. Mol Cell Endocrinol 189:1–9

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rolipram and pentoxifylline combination ameliorates the morphological abnormalities of dorsal root ganglion neurons in experimental diabetic neuropathy by reducing mitochondrial dysfunction and apoptosis;Journal of Biochemical and Molecular Toxicology;2023-07-11

2. Phosphodiesterase inhibitors and lung diseases;Advances in Pharmacology;2023

3. Rolipram and pentoxifylline combination ameliorates experimental diabetic neuropathy through inhibition of oxidative stress and inflammatory pathways in the dorsal root ganglion neurons;Metabolic Brain Disease;2022-08-04

4. Phosphodiesterase 4 mediates interleukin‐8‐induced heterologous desensitization of the β 2 ‐adrenergic receptor;The FASEB Journal;2021-09-23

5. Phosphodiesterase Inhibitors in Acute Lung Injury: What Are the Perspectives?;International Journal of Molecular Sciences;2021-02-16